Evidence map›Paper›PMID 35607830›Full record

ArticleEMBO reports2022

Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteins.

Souheyla Benfrid, Kyu-Ho Park, Mariano Dellarole, James E Voss, Carole Tamietti, Gérard Pehau-Arnaudet, Bertrand Raynal, Sébastien Brûlé, Patrick England, Xiaokang Zhang and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Dengue NS1 as a Driver of Immune-Mediated Pathogenesis.Tropical medicine and infectious disease · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Dengue Virus NS1 Binds Ephrin B1 to Trigger Endothelial Dysfunction.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Recommendations for dengue vaccine implementation in the elderly population.Therapeutic advances in vaccines and immunotherapy · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 5 countries.

Souheyla Benfrid *Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.
Kyu-Ho Park *Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.ORCID 0000-0001-9493-9577
Mariano DellaroleUnité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.ORCID 0000-0001-8044-4717
James E VossUnité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.
Carole TamiettiUnité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.
Gérard Pehau-ArnaudetUTECH UBI, Institut Pasteur and CNRS UMR 3528, Paris, France.ORCID 0000-0001-6479-9470
Bertrand RaynalMolecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.
Sébastien BrûléMolecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.ORCID 0000-0002-8797-6748
Patrick EnglandMolecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.ORCID 0000-0001-6410-5918
Xiaokang ZhangUnité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.
Anastassia MikhailovaHIV Inflammation et Persistance, Institut Pasteur, Paris, France.
Milena HasanCytometry and Biomarkers Unit of Technology and Service, CB UTechS, Paris, France.
Marie-Noëlle UngeheuerICAReB, Institut Pasteur, Paris, France.ORCID 0000-0002-1639-9613
Stéphane PetresProduction and Purification of Recombinant Proteins Facility, Institut Pasteur, Paris, France.ORCID 0000-0002-4716-565X
Scott B BieringDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA.ORCID 0000-0003-1991-629X
Eva HarrisDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA.ORCID 0000-0002-7238-4037
Anavaj SakuntabhaiHuman Genetics, Institut Pasteur, Paris, France.
Philippe BuchyVirology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.
Veasna DuongVirology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.ORCID 0000-0003-0353-1678
Philippe DussartVirology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.ORCID 0000-0002-1931-3037
Fasséli CoulibalyDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, Vic., Australia.
François BontemsUnité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.
Félix A ReyUnité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.ORCID 0000-0002-9953-7988
Marie FlamandUnité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.ORCID 0000-0002-7104-7418
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FRInstitut Pasteur du Cambodge · KHUniversity of California, Berkeley · USDélégation Paris 5 · FRMonash University · AUScripps Research Institute · US

Funding

Dissecting novel mechanisms of dengue virus NS1-induced vascular leakR01AI124493 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARRIS, EVA · 2016 to 2020
$1.9M
Evaluation of in vitro and in vivo efficacy of glycan-based compounds against flavivirus endothelial permeability and vascular leakR21AI146464 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARRIS, EVA · 2020 to 2021
$886k
NIAID NIH HHS R01 AI124493NIAID NIH HHS R21 AI146464
6 · The paper itself

Abstract

The dengue virus nonstructural protein 1 (NS1) is a secreted virulence factor that modulates complement, activates immune cells and alters endothelial barriers. The molecular basis of these events remains incompletely understood. Here we describe a functional high affinity complex formed between NS1 and human high-density lipoproteins (HDL). Collapse of the soluble NS1 hexamer upon binding to the lipoprotein particle leads to the anchoring of amphipathic NS1 dimeric subunits into the HDL outer layer. The stable complex can be visualized by electron microscopy as a spherical HDL with rod-shaped NS1 dimers protruding from the surface. We further show that the assembly of NS1-HDL complexes triggers the production of pro-inflammatory cytokines in human primary macrophages while NS1 or HDL alone do not. Finally, we detect NS1 in complex with HDL and low-density lipoprotein (LDL) particles in the plasma of hospitalized dengue patients and observe NS1-apolipoprotein E-positive complexes accumulating overtime. The functional reprogramming of endogenous lipoprotein particles by NS1 as a means to exacerbate systemic inflammation during viral infection provides a new paradigm in dengue pathogenesis.

Indexed as

DengueDengue VirusHumansLipoproteins, HDLPhagocytosisViral Nonstructural ProteinsLipoproteins, HDLViral Nonstructural Proteinsaccessory proteinArbovirushemorrhagic feverlipoprotein particlemolecular pathogenesisvirulence factor

Identifiers

PMID35607830
PMCPMC10549233
OpenAlexW4282924272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.